CN114956969B - Preparation method of 4-ethoxy-1, 1-trifluoro-3-butene-2-ketone - Google Patents
Preparation method of 4-ethoxy-1, 1-trifluoro-3-butene-2-ketone Download PDFInfo
- Publication number
- CN114956969B CN114956969B CN202210815464.2A CN202210815464A CN114956969B CN 114956969 B CN114956969 B CN 114956969B CN 202210815464 A CN202210815464 A CN 202210815464A CN 114956969 B CN114956969 B CN 114956969B
- Authority
- CN
- China
- Prior art keywords
- organic
- trifluoro
- ethoxy
- trifluoroacetyl chloride
- organic solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical group CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 29
- PNQBEPDZQUOCNY-UHFFFAOYSA-N trifluoroacetyl chloride Chemical compound FC(F)(F)C(Cl)=O PNQBEPDZQUOCNY-UHFFFAOYSA-N 0.000 claims abstract description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Natural products CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 18
- 150000007530 organic bases Chemical class 0.000 claims abstract description 14
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000005406 washing Methods 0.000 claims abstract description 12
- -1 vinyl diethyl ether Chemical compound 0.000 claims abstract description 9
- 229920002554 vinyl polymer Polymers 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000003513 alkali Substances 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000012044 organic layer Substances 0.000 claims description 23
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 21
- 239000003960 organic solvent Substances 0.000 claims description 16
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 11
- 238000004821 distillation Methods 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- 239000010410 layer Substances 0.000 claims description 7
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical group CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 6
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 claims description 6
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 238000011084 recovery Methods 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 29
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract description 27
- 239000002904 solvent Substances 0.000 abstract description 19
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract description 13
- 238000001704 evaporation Methods 0.000 abstract description 6
- 230000015556 catabolic process Effects 0.000 abstract description 5
- 238000006731 degradation reaction Methods 0.000 abstract description 5
- 238000003912 environmental pollution Methods 0.000 abstract description 5
- 239000012467 final product Substances 0.000 abstract description 4
- 238000005070 sampling Methods 0.000 description 16
- 238000009423 ventilation Methods 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 11
- 238000001228 spectrum Methods 0.000 description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 229910000831 Steel Inorganic materials 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 239000010959 steel Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000009776 industrial production Methods 0.000 description 7
- 238000004321 preservation Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 6
- 239000012535 impurity Substances 0.000 description 5
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000575 pesticide Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 238000005292 vacuum distillation Methods 0.000 description 2
- SEFCEFBQHKAEKE-UHFFFAOYSA-M 1-methylpyridin-1-ium;2,2,2-trifluoroacetate Chemical group C[N+]1=CC=CC=C1.[O-]C(=O)C(F)(F)F SEFCEFBQHKAEKE-UHFFFAOYSA-M 0.000 description 1
- 206010008590 Choking sensation Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241001539473 Euphoria Species 0.000 description 1
- 206010015535 Euphoric mood Diseases 0.000 description 1
- 208000034347 Faecal incontinence Diseases 0.000 description 1
- 239000005900 Flonicamid Substances 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000008238 Muscle Spasticity Diseases 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 239000005934 Sulfoxaflor Substances 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- RLQJEEJISHYWON-UHFFFAOYSA-N flonicamid Chemical compound FC(F)(F)C1=CC=NC=C1C(=O)NCC#N RLQJEEJISHYWON-UHFFFAOYSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000002608 ionic liquid Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000007867 post-reaction treatment Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 208000018198 spasticity Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/455—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation with carboxylic acids or their derivatives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
- B01J31/0235—Nitrogen containing compounds
- B01J31/0241—Imines or enamines
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
- B01J31/0235—Nitrogen containing compounds
- B01J31/0244—Nitrogen containing compounds with nitrogen contained as ring member in aromatic compounds or moieties, e.g. pyridine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
- B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
- B01J2231/4205—C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Abstract
The invention provides a preparation method of 4-ethoxy-1, 1-trifluoro-3-butene-2-ketone, which comprises the following steps of: the preparation method comprises the steps of reacting trifluoroacetyl chloride with vinyl diethyl ether as a raw material, and performing aftertreatment to obtain 4-ethoxy-1, 1-trifluoro-3-butene-2-one, wherein the organic base is selected from N-methylmorpholine and/or N-methylimidazole. According to the invention, the pyridine is replaced by the N-methylmorpholine or N-methylimidazole, so that the quality of the product is improved, the environmental pollution is reduced, the alkali residue can be effectively removed after washing in the post-treatment process, and the problem of degradation of the final product in the solvent evaporating process is solved.
Description
Technical Field
The invention relates to the field of chemical synthesis, in particular to a preparation method of 4-ethoxy-1, 1-trifluoro-3-butene-2-ketone.
Background
The 4-ethoxy-1, 1-trifluoro-3-butene-2-ketone has active performance, and can be used as a raw material to synthesize a series of compounds containing trifluoromethyl, which are widely applied to the fields of medicines, pesticides, materials and the like. In the field of medicine, 4-ethoxy-1, 1-trifluoro-3-buten-2-one can be used for synthesizing antiviral drugs, anticancer drugs, anti-inflammatory drugs and the like; in the field of pesticides, 4-ethoxy-1, 1-trifluoro-3-buten-2-one has been successfully used for the industrialized preparation of commercial pesticides flonicamid and sulfoxaflor; in the field of materials, 4-ethoxy-1, 1-trifluoro-3-buten-2-one can be used for preparing metal ligands, ionic liquids and parting agents. The synthesis method is reported at home and abroad.
The synthesis methods of 4-ethoxy-1, 1-trifluoro-3-buten-2-one in the literature mainly comprise the following steps:
(1) The method has the advantages that the trifluoroacetic anhydride and vinyl ether are used as raw materials to react in a solvent in the presence of alkali, one molecule of trifluoroacetic acid generated after the trifluoroacetic anhydride reacts is not involved in the reaction, and the raw material utilization rate is low.
(2) Many researchers have also performed addition reaction of trifluoroacetyl chloride and vinyl ether in a solvent in the presence of a base, including pyridine, quinoline, triethylamine, dimethylaniline, diethylaniline, 4-dimethylaminopyridine, etc.; or the hydrogen chloride can be eliminated after addition, and the reaction product can be neutralized by heating or adding alkali. However, only pyridine is suitable for industrial production, but pyridine has malodor and strong irritation; can anesthetize central nervous system. Has stimulating effect on eyes and upper respiratory tract. After high concentration inhalation, the lighter people have euphoria or choking sensation, and then depression, muscle weakness and vomiting appear; loss of consciousness, incontinence of urine and faeces, spasticity, and blood pressure decrease in the serious patients. Misadministration can be fatal. Long-term inhalation is manifested by dizziness, headache, insomnia, gait instability and digestive tract dysfunction. Liver and kidney damage can occur. Dermatitis can be caused. Therefore, the requirements on workshop production conditions are high.
(3) Researchers have also performed addition reactions of trifluoroacetyl chloride with vinyl ether in the absence of solvents, removing hydrogen chloride by heating or low pressure. The trifluoroacetic acid is needed to prepare the trifluoroacetyl chloride, the impurities of the product are more when the solvent is not used in heating, the post-reaction treatment is complex, the environmental pollution is serious, and the method is not suitable for industrial production.
(4) Patent CN1330622C reacts vinyl ethyl ether with trifluoroacetyl chloride or trifluoroacetic anhydride in the presence of an onium salt of trifluoroacetic acid at room temperature. The solvent includes dichloromethane, hexane, etc., and the onium salt is preferably methyl pyridinium trifluoroacetate. The trifluoroacetic acid and pyridine are required to be firstly used as onium salts, so that the production cost is high, the environmental pollution is serious, and the method is not suitable for industrial production.
In conclusion, the existing preparation method of 4-ethoxy-1, 1-trifluoro-3-buten-2-one has the defects of harsh reaction conditions, serious environmental pollution, complicated post-treatment steps, low reaction yield, high production cost, unfavorable industrial production and the like.
Disclosure of Invention
Object of the Invention
In order to overcome the defects, the invention aims to provide the preparation method of the 4-ethoxy-1, 1-trifluoro-3-butene-2-ketone, which has the advantages of few reaction steps, mild reaction conditions, environment friendliness, simple post-treatment steps, high reaction yield, high product purity and low production cost, and is suitable for industrial production.
Solution scheme
In order to achieve the purpose of the invention, the technical scheme adopted by the invention is as follows:
in a first aspect, the present invention provides a method for preparing 4-ethoxy-1, 1-trifluoro-3-buten-2-one, comprising the steps of: the preparation method comprises the steps of reacting trifluoroacetyl chloride with vinyl diethyl ether as a raw material, and performing aftertreatment to obtain 4-ethoxy-1, 1-trifluoro-3-butene-2-one, wherein the organic base is selected from N-methylmorpholine and/or N-methylimidazole.
Further, the post-treatment method includes washing with water, drying, and recovering the organic solvent.
Further, the water washing method comprises the following steps: water was added until the solids dissolved, the layers were separated by standing and the organic layer was dried.
Further, the aqueous layer is used for recovering the organic base.
Further, the organic layer was dried over anhydrous magnesium sulfate.
Further, the method for evaporating and recovering the organic solvent is to control the temperature to be lower than 50 ℃, and the vacuum distillation is carried out, and optionally, the vacuum degree is-0.09 to-0.1 Mpa. The evaporation to dryness to recover the solvent means that the dried organic layer is distilled under reduced pressure to recover the organic solvent.
Further, the molar ratio of the vinyl ethyl ether to the organic base is 1:1-1:5, preferably 1:1-1:2.
Further, the molar ratio of trifluoroacetyl chloride to vinyl ether is 1:1-2:1, preferably 1:1-1.1:1.
Further, the organic base is N-methylmorpholine.
Further, the feeding sequence is as follows: firstly adding vinyl diethyl ether, an organic solvent and an organic base, and then introducing trifluoroacetyl chloride gas for reaction.
Further, the organic solvent adopts alkane substituted by chlorine; alternatively, the organic solvent is dichloroethane or dichloromethane.
Further, the reaction temperature is 0-10 ℃.
Further, the reaction time after the trifluoroacetyl chloride is introduced is 0.5 to 3 hours.
Advantageous effects
(1) According to the invention, the pyridine is replaced by the N-methylmorpholine or N-methylimidazole, so that the quality of the product is improved, the environmental pollution is reduced, the alkali residue can be effectively removed after washing in the post-treatment process, and the problem of degradation of the final product in the solvent evaporating process is solved. Mainly because the inventors of the present invention found that pyridine could not be completely removed by washing with water, and residual pyridine could cause degradation of the final product. The inventor of the invention discovers that the adoption of N-methylmorpholine or N-methylimidazole can not only improve the reaction yield and quality, but also remove the residue through simple water washing, thereby not only effectively recycling the organic solvent, but also reducing the possibility of degradation of the final product.
(2) The method has the advantages of mild reaction conditions, simple post-treatment steps, high reaction yield, high product purity and low production cost, and is suitable for industrial production.
Drawings
One or more embodiments are illustrated by way of example and not limitation in the figures of the accompanying drawings. The word "exemplary" is used herein to mean "serving as an example, embodiment, or illustration. Any embodiment described herein as "exemplary" is not necessarily to be construed as preferred or advantageous over other embodiments.
Fig. 1: GC spectra of example 1 of the present invention for sample detection of dried organic layers; wherein, the product (4-ethoxy-1, 1-trifluoro-3-buten-2-one) is about 5 min.
Fig. 2: GC spectrogram of the product sampling detection of example 1 of the present invention; wherein, the product (4-ethoxy-1, 1-trifluoro-3-buten-2-one) is about 5 min.
Fig. 3: GC spectra of example 2 of the present invention for sample detection of dried organic layers; wherein, the product (4-ethoxy-1, 1-trifluoro-3-buten-2-one) is about 5 min.
Fig. 4: GC spectra of comparative example 1 of the invention for sampling detection of dried organic layers; wherein 3.9min is residual pyridine, and about 5min is the product (4-ethoxy-1, 1-trifluoro-3-buten-2-one).
Fig. 5: the GC spectrogram of the distilled residue liquid sampling detection of the comparative example 1; wherein, the product (4-ethoxy-1, 1-trifluoro-3-buten-2-one) is about 5 min.
Fig. 6: GC spectra of comparative example 3 of the present invention for sample detection of dried organic layer; wherein, the product (4-ethoxy-1, 1-trifluoro-3-buten-2-one) is about 5 min.
Fig. 7: GC spectra of comparative example 4 of the present invention for sample detection of dried organic layer; wherein, the product (4-ethoxy-1, 1-trifluoro-3-buten-2-one) is about 5 min.
Wherein, the peaks about 3min in figures 1, 3, 4, 6 and 7 are mainly organic solvents, and can be evaporated to dryness in the distillation process in the later stage.
Detailed Description
For the purpose of making the objects, technical solutions and advantages of the embodiments of the present invention more apparent, the technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is apparent that the described embodiments are some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
In addition, numerous specific details are set forth in the following description in order to provide a better illustration of the invention. It will be understood by those skilled in the art that the present invention may be practiced without some of these specific details. In some embodiments, materials, elements, methods, means, etc. well known to those skilled in the art are not described in detail in order to highlight the gist of the present invention.
Throughout the specification and claims, unless explicitly stated otherwise, the term "comprise" or variations thereof such as "comprises" or "comprising", etc. will be understood to include the stated element or component without excluding other elements or components.
In the following examples, the spectrum refers to GC spectrum, i.e. gas chromatography detection. The temperature is lower than 50 ℃ when the solvent is recovered, the vacuum distillation is carried out, and the vacuum degree is between-0.09 and-0.1 Mpa.
Example 1
25g of vinyl ether, 100ml of dichloromethane and 38.1. 38.1g N-methylmorpholine are put into a 250ml four-mouth bottle, the system is closed, the temperature is reduced to 0-10 ℃, trifluoroacetyl chloride gas is introduced into the system through a steel bottle, and the reaction temperature is maintained at 0-10 ℃. Stopping ventilation after the ventilation amount reaches 45.5g, carrying out heat preservation reaction for 1h, adding 80g of water after sampling analysis is qualified, stirring until the solid is completely dissolved for 10min, standing for layering, recovering N-methylmorpholine from a water layer, drying an organic layer by using anhydrous sodium sulfate, sampling and detecting the dried organic layer, and obtaining a spectrogram result shown in figure 1. After recovering the solvent by distillation under reduced pressure, a product with a GC purity of 99% was obtained, and a sample of the product was shown in FIG. 2. The yield was 99.5%,100% was cis structure.
Example 2
25g of vinyl ether, 150ml of dichloroethane and 30.8-g N-methylimidazole are put into a 250ml four-mouth bottle, the system is closed, the temperature is reduced to 0-10 ℃, and trifluoroacetyl chloride gas is introduced into the system through a steel bottle, and the reaction temperature is maintained at 0-10 ℃. Stopping ventilation after the ventilation amount reaches 45.5g, carrying out heat preservation reaction for 1h, adding 80g of water after sampling analysis is qualified, stirring until the solid is completely dissolved for 10min, standing for layering, recovering N-methylimidazole from the water layer, drying the organic layer by using anhydrous magnesium sulfate, sampling and detecting the dried organic layer, and obtaining a spectrogram result shown in figure 3. The solvent was recovered by distillation under reduced pressure to give a product with a GC purity of 99% and a yield of 99% with a cis structure of 100%.
Example 3
25g of vinyl diethyl ether, 100ml of dichloroethane and 38.1. 38.1g N-methylmorpholine are put into a 250ml four-mouth bottle, the system is closed, the temperature is reduced to 0-10 ℃, and trifluoroacetyl chloride gas is introduced into the system through a steel bottle, and the reaction temperature is maintained at 0-10 ℃. Stopping ventilation after the ventilation amount reaches 45.5g, carrying out heat preservation reaction for 1h, adding 80g of water after sampling analysis is qualified, stirring until the solid is completely dissolved for 10min, standing for layering, recovering N-methylmorpholine from the water layer, and drying the organic layer by using anhydrous sodium sulfate. The solvent was recovered by distillation under reduced pressure to give a product having a GC purity of 99% (almost no impurity peak as a result of the GC spectrum) and a yield of 99% and a cis structure of 100%.
Example 4
25g of vinyl ether, 150ml of dichloromethane and 30.8. 30.8g N-methylimidazole are put into a 250ml four-mouth bottle, the system is closed, the temperature is reduced to 0-10 ℃, trifluoroacetyl chloride gas is introduced into the system through a steel bottle, and the reaction temperature is maintained at 0-10 ℃. Stopping ventilation after the ventilation amount reaches 45.5g, carrying out heat preservation reaction for 1h, adding 80g of water after sampling analysis is qualified, stirring until the solid is completely dissolved for 10min, standing for layering, recovering N-methylimidazole from the water layer, and drying the organic layer by using anhydrous magnesium sulfate. The solvent was recovered by distillation under reduced pressure to give a product with a GC purity of 99.4% in a yield of 99.2% and 100% in cis.
The above examples 1 to 4 illustrate that the organic base (N-methylmorpholine or N-methylimidazole) is effectively removed by simple washing with water and drying, and the product has no impurity peak (i.e., no impurity) after the solvent is recovered by evaporation to dryness, which means that the specific organic base (N-methylmorpholine or N-methylimidazole) selected in the invention is not only easily removed by washing with water, but also can improve the yield and the productivity of the product, and the post-treatment steps are simple and easy to operate, thereby being suitable for industrial production.
Comparative example 1
25g of vinyl ether, 150ml of dichloromethane and 30.0g of pyridine are put into a 250ml four-mouth bottle, the system is closed, the temperature is reduced to 0-10 ℃, trifluoroacetyl chloride gas is introduced into the system through a steel bottle, and the reaction temperature is maintained at 0-10 ℃. Stopping ventilation after the ventilation amount reaches 45.5g, carrying out heat preservation reaction for 1h, adding 80g of water after sampling analysis is qualified, stirring until the solid is completely dissolved for 10min, standing for layering, drying the organic layer by using anhydrous magnesium sulfate, sampling and detecting the dried organic layer, and the spectrogram result is shown in figure 4. The solvent was recovered by distillation under reduced pressure to give a product with a GC purity of 97% in 92% yield and 100% in cis structure. The sample spectrum of the distilled residue (the residue containing the product and trace solvent at the later stage of reduced pressure distillation) is shown in FIG. 5, and the distilled residue is further purified to obtain the satisfactory product.
The results of comparative example 1 show that the spectrum peak in fig. 5 is relatively simple compared with fig. 4, but the amount of the organic solvent in fig. 5 is obviously reduced, but more miscellaneous peaks appear, the yield is also reduced, the organic solvent is recovered by a solvent evaporation method when pyridine is adopted, the production is not easy to carry out, and the inventor finds that the pyridine cannot be effectively removed in the water washing process through continuous analysis, and trace pyridine residues degrade the product in the evaporation process. The inventor has found through continuous attempts and experiments that N-methylmorpholine or N-methylimidazole can be effectively removed by water washing, so that the product degradation is reduced while the reaction yield is improved.
Comparative example 2
25g of vinyl diethyl ether, 150ml of dichloroethane and 30.0g of pyridine are put into a 250ml four-mouth bottle, the system is closed, the temperature is reduced to 0-10 ℃, trifluoroacetyl chloride gas is introduced into the system through a steel bottle, and the reaction temperature is maintained at 0-10 ℃. Stopping ventilation after the ventilation amount reaches 45.5g, preserving heat for reaction for 1h, adding 80g of water after sampling and analysis are qualified, stirring until the solid is completely dissolved for 10min, standing for layering, drying an organic layer by using anhydrous magnesium sulfate, and distilling under reduced pressure to recover the solvent to obtain a product with GC purity of 96% (the GC spectrogram shows that the product has a miscellaneous peak and possibly is degraded), wherein the yield is 90% and 100% is in a cis structure.
Comparative example 3
25g of vinyl ether, 150ml of dichloromethane and 30.8g of triethylamine are put into a 250ml four-mouth bottle, the system is closed, the temperature is reduced to 0-10 ℃, and trifluoroacetyl chloride gas is introduced into the system through a steel bottle, and the reaction temperature is maintained at 0-10 ℃. Stopping ventilation after the ventilation amount reaches 45.5g, carrying out heat preservation reaction for 1h, adding 80g of water after sampling analysis is qualified, stirring until the solid is completely dissolved for 10min, standing for layering, drying the organic layer by using anhydrous magnesium sulfate, sampling and detecting the dried organic layer, and the spectrogram result is shown in figure 6. The solvent was recovered by distillation under reduced pressure to give the product with GC purity 95% and yield 70% and 100% in cis structure.
This comparative example 3 illustrates that the use of triethylamine as the base may be detrimental to the reaction due to too strong basicity and the reaction may be more contaminated.
Comparative example 4
25g of vinyl ether, 150ml of dichloroethane and 35.0g of diisopropylethylamine are put into a 250ml four-necked flask, the system is closed, the temperature is reduced to 0-10 ℃, and trifluoroacetyl chloride gas is introduced into the system through a steel bottle, and the reaction temperature is maintained at 0-10 ℃. Stopping ventilation after the ventilation amount reaches 45.5g, carrying out heat preservation reaction for 1h, adding 80g of water after sampling analysis is qualified, stirring until the solid is completely dissolved for 10min, standing for layering, drying the organic layer by using anhydrous magnesium sulfate, sampling and detecting the dried organic layer, and the spectrogram result is shown in figure 7. The solvent was recovered by distillation under reduced pressure to give the product with GC purity 96% and yield 40% and 100% in cis structure.
This comparative example 4 illustrates that diisopropylethylamine as a base may be too basic to facilitate the reaction, and impurities are more abundant in the reaction.
Finally, it should be noted that: the above embodiments are only for illustrating the technical solution of the present invention, and are not limiting; although the invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical scheme described in the foregoing embodiments can be modified or some technical features thereof can be replaced by equivalents; such modifications and substitutions do not depart from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims (14)
1. A preparation method of 4-ethoxy-1, 1-trifluoro-3-buten-2-one is characterized in that in an organic solvent, under the condition of existence of organic alkali: reacting trifluoroacetyl chloride with vinyl diethyl ether as raw material, post-treating to obtain 4-ethoxy-1, 1-trifluoro-3-butene-2-ketone,
the organic base is selected from N-methylmorpholine and/or N-methylimidazole;
the mol ratio of the vinyl diethyl ether to the organic base is 1:1-1:5;
the molar ratio of the trifluoroacetyl chloride to the vinyl diethyl ether is 1:1-2:1.
2. The method of claim 1, wherein the post-treatment process comprises washing with water, drying, and recovering the organic solvent.
3. The method according to claim 2, wherein the water washing method comprises: adding water until the solid is dissolved, standing and layering; the organic layer was dried.
4. A process according to claim 3, wherein the aqueous layer is used for recovery of organic bases.
5. The method according to claim 3, wherein the organic layer is dried over anhydrous magnesium sulfate.
6. The method according to claim 2, wherein the method for recovering the organic solvent is: controlling the temperature below 50deg.C, and distilling under reduced pressure.
7. The process according to claim 6, wherein the vacuum degree of reduced pressure distillation is-0.09 to-0.1 MPa.
8. The method according to claim 1, wherein the molar ratio of vinyl ethyl ether to organic base is 1:1 to 1:2.
9. The process according to claim 1, wherein the molar ratio of trifluoroacetyl chloride to vinyl ether is 1:1 to 1.1:1.
10. The process according to claim 1, wherein the organic base is N-methylmorpholine.
11. The method according to any one of claims 1 to 10, wherein the order of addition is: firstly adding vinyl diethyl ether, an organic solvent and an organic base, and then introducing trifluoroacetyl chloride gas for reaction.
12. The method according to any one of claims 1 to 10, wherein the organic solvent is a chlorine-substituted alkane.
13. The preparation method according to any one of claims 1 to 10, wherein the organic solvent is dichloroethane or dichloromethane.
14. The preparation method according to any one of claims 1 to 10, wherein the reaction temperature is 0 to 10 ℃;
and/or the reaction time after the trifluoroacetyl chloride is introduced is 0.5 to 3 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210815464.2A CN114956969B (en) | 2022-07-12 | 2022-07-12 | Preparation method of 4-ethoxy-1, 1-trifluoro-3-butene-2-ketone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210815464.2A CN114956969B (en) | 2022-07-12 | 2022-07-12 | Preparation method of 4-ethoxy-1, 1-trifluoro-3-butene-2-ketone |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114956969A CN114956969A (en) | 2022-08-30 |
CN114956969B true CN114956969B (en) | 2024-04-16 |
Family
ID=82970223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210815464.2A Active CN114956969B (en) | 2022-07-12 | 2022-07-12 | Preparation method of 4-ethoxy-1, 1-trifluoro-3-butene-2-ketone |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114956969B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5708175A (en) * | 1995-05-26 | 1998-01-13 | Ishihara Sangyo Kaisha Ltd. | Process for producing 4-trifluoromethylnicotinic acid |
CN1628087A (en) * | 2002-02-08 | 2005-06-15 | 索尔微氟及衍生物有限公司 | Production of alkenones |
-
2022
- 2022-07-12 CN CN202210815464.2A patent/CN114956969B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5708175A (en) * | 1995-05-26 | 1998-01-13 | Ishihara Sangyo Kaisha Ltd. | Process for producing 4-trifluoromethylnicotinic acid |
CN1628087A (en) * | 2002-02-08 | 2005-06-15 | 索尔微氟及衍生物有限公司 | Production of alkenones |
Also Published As
Publication number | Publication date |
---|---|
CN114956969A (en) | 2022-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114956969B (en) | Preparation method of 4-ethoxy-1, 1-trifluoro-3-butene-2-ketone | |
CN109096213A (en) | A kind of preparation method of 1H-1,2,3- triazole | |
CN109942459B (en) | Method for synthesizing 3-difluoromethyl-3-acrylonitrile compounds | |
CN115806543A (en) | Articaine hydrochloride intermediate and preparation method and application thereof | |
EP3608309A1 (en) | Method for purifying trifluoromethylpyridine compound | |
CN111574416B (en) | Method for preparing tiamulin from isothiourea salt and pleuromutilin p-toluenesulfonate | |
CN109265385B (en) | Synthesis process of chiral catalyst | |
CN109369357B (en) | Method for preparing symmetrical diaryl ketone by catalytic oxidation carbonylation | |
CN117003692B (en) | Process for producing difluoromethyl (2-pyridyl) sulfone | |
CN115611768B (en) | Synthesis method of 3, 4-dichlorobenzonitrile | |
CN112694450B (en) | Preparation method of 4-methyl-5-ethoxy oxazole | |
JP2001278867A (en) | Method for producing cyclic acid | |
CN114349690B (en) | Synthesis method of doravirine intermediate | |
CN114163309B (en) | Preparation method of doravirine intermediate | |
CN110818679B (en) | Synthetic method of 4-bromobenzo [ b ] thiophene | |
CN113896646B (en) | Efficient green preparation method of 4-methyl-3-oxo-N-phenyl valeramide | |
US4845301A (en) | Process for the preparation of α-hdroxyketones | |
CN117327021A (en) | Method for removing sticky impurities in hexahydropyridazine synthesis | |
CN117447350A (en) | Comprehensive recycling method for atorvastatin M4 organic waste | |
CN111533699A (en) | Synthetic method of 2- (trifluoromethyl) pyrimidine-5-ol | |
CN108069897B (en) | Method for synthesizing nicotinic acid by using carbon dioxide | |
CN115181043A (en) | Method for preparing 4-isothiocyanato-2- (trifluoromethyl) benzonitrile by continuous flow | |
DE2636384A1 (en) | PROCESS FOR THE PREPARATION OF N, N-DIAETHYL-2- (ALPHA-NAPHTHOXY) -PROPIONAMIDE | |
CN115650895A (en) | Simple synthesis method of 3, 3-dimethylpyrrolidin-2-one | |
CN116924936A (en) | Preparation method of dabigatran intermediate compound p-aminobenzonitrile |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |